September 16, 2024 |
Adobe Inc. (ADBE)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Adobe Inc. (“Adobe” or “the Company”) (NASDAQ: ADBE). Investors who purchased Adobe securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Adobe has violated federal… read more
September 12, 2024 |
Aviat Networks, Inc. (AVNW)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aviat Networks, Inc. (“Aviat” or “the Company”) (NASDAQ: AVNW). Investors who purchased Aviat securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Aviat has violated… read more
September 12, 2024 |
Fulcrum Therapeutics, Inc. (FULC)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fulcrum Therapeutics, Inc. (“Fulcrum” or “the Company”) (NASDAQ: FULC). Investors who purchased Fulcrum securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Fulcrum has violated… read more
September 9, 2024 |
Mineralys Therapeutics, Inc. (MLYS)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Mineralys Therapeutics, Inc. (“Mineralys” or “the Company”) (NASDAQ: MLYS). Investors who purchased Mineralys securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Mineralys has violated… read more
August 30, 2024 |
Dollar General Corporation (DG)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dollar General Corporation (“Dollar General” or “the Company”) (NYSE: DG). Investors who purchased Dollar General securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Dollar… read more
August 28, 2024 |
Lions Gate Entertainment Corporation (LGF)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lions Gate Entertainment Corporation (“Lionsgate” or “the Company”) (NYSE: LGF.A; LGF.B). Investors who purchased Lionsgate securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Lionsgate… read more
August 28, 2024 |
Lions Gate Entertainment Corporation (LGF.A; LGF.B)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lions Gate Entertainment Corporation (“Lionsgate” or “the Company”) (NYSE: LGF.A; LGF.B). Investors who purchased Lionsgate securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Lionsgate… read more
August 28, 2024 |
Bank Of Montreal (BMO)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bank Of Montreal (“BoM” or “the Company”) (NYSE: BMO). Investors who purchased BoM securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether BoM has violated… read more
August 27, 2024 |
MaxLinear, Inc (MXL)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MaxLinear, Inc (“MaxLinear” or “the Company”) (NYSE: MXL). Investors who purchased MaxLinear securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether MaxLinear has violated federal… read more
August 27, 2024 |
Endeavour Silver Corporation (EXK)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Endeavour Silver Corporation (“Endeavour” or “the Company”) (NYSE: EXK). Investors who purchased Endeavour securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Endeavour has violated… read more
August 27, 2024 |
Mynaric AG (MYNA)
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Mynaric AG (“Mynaric” or “the Company”) (NASDAQ: MYNA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for… read more
August 27, 2024 |
Owlet, Inc. (OWLT)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sandbridge Acquisition Corporation (“Sandbridge”), which merged with Owlet, Inc. (“Owlet”) (NYSE: OWLT) on July 15, 2021. Investors who purchased Sandbridge shares prior to June 1, 2021, and continue to hold Owlet… read more
August 26, 2024 |
Liquidia Technologies, Inc. (LQDA)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Liquidia Technologies, Inc. (“Liquidia” or “the Company”) (NASDAQ: LQDA). Investors who purchased Liquidia securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Liquidia has violated… read more
August 23, 2024 |
Syros Pharmaceuticals, Inc. (SYRS)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Syros Pharmaceuticals, Inc. (“Syros” or “the Company”) (NASDAQ: SYRS). Investors who purchased Syros securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Syros has violated… read more
August 14, 2024 |
Kellanova (K)
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Mars, Inc. (“Mars”) and Kellanova (NYSE: K). Investors who purchased Kellanova and continue to hold to the present are encouraged to obtain additional information and assist the investigation Investigation Details The investigation concerns whether Kellanova… read more
August 14, 2024 |
Globus Medical, Inc. (GMED)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globus Medical, Inc. (“Globus Medical” or “the Company”) (NYSE: GMED). Investors who purchased Globus Medical securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Globus… read more
August 14, 2024 |
Extreme Networks, Inc. (EXTR)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Extreme Networks, Inc. (“Extreme Networks” or “the Company”) (NASDAQ: EXTR). Investors who purchased Extreme Networks securities prior to July 27, 2022, and continue to hold to the present, are encouraged to… read more
August 6, 2024 |
Brookfield Business Partners L.P. (BBU)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Brookfield Business Partners L.P. (“Brookfield” or “the Company”) (NYSE: BBU). Investors who purchased Brookfield securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Brookfield has… read more
August 6, 2024 |
Proto Labs, Inc. (PRLB)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Proto Labs, Inc. (“Proto Labs” or “the Company”) (NYSE: PRLB). Investors who purchased Proto Labs securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Proto… read more
August 5, 2024 |
PowerSchool Holdings, Inc. (PWSC)
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between PowerSchool Holdings, Inc. (“PowerSchool”) (NYSE: PWSC) and Bain Capital (“Bain”). Investors who purchased PowerSchool and continue to hold to the present are encouraged to obtain additional information and assist the investigation Investigation Details The investigation… read more
August 5, 2024 |
BrightSpring Health Services, Inc. (BTSG)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BrightSpring Health Services, Inc. (“BrightSpring” or “the Company”) (NASDAQ: BTSG). Investors who purchased BrightSpring securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether BrightSpring has… read more
August 2, 2024 |
Zentalis Pharmaceuticals, Inc. (ZNTL)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zentalis Pharmaceuticals, Inc. (“Zentalis” or “the Company”) (NASDAQ: ZNTL). Investors who purchased Zentalis securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Zentalis has violated… read more
August 1, 2024 |
W.P. Carey Inc. (WPC)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of W.P. Carey Inc. (“W.P. Carey” or “the Company”) (NYSE: WPC). Investors who purchased W.P. Carey securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether W.P…. read more
August 1, 2024 |
AvidXchange Holdings, Inc. (AVDX)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AvidXchange Holdings, Inc. (“AvidXchange” or “the Company”) (NASDAQ: AVDX). Investors who purchased AvidXchange securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether AvidXchange has violated… read more
July 31, 2024 |
Metagenomi, Inc. (MGX)
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Metagenomi, Inc. (“Metagenomi” or “the Company”) (NASDAQ: MGX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for… read more
July 31, 2024 |
LPL Financial Holdings Inc. (LPLA)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of LPL Financial Holdings Inc. (“LPL” or “the Company”) (NASDAQ: LPLA). Investors who purchased LPL securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether LPL has… read more
July 31, 2024 |
Conn’s, Inc. (CONN)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Conn’s, Inc. (“Conn’s” or “the Company”) (NASDAQ: CONN). Investors who purchased Conn’s securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Conn’s has violated federal… read more
July 31, 2024 |
Xiao-I Corp. (AIXI)
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Xiao-I Corp. (“Xiao-I” or “the Company”) (NASDAQ: AIXI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for… read more
July 30, 2024 |
SmartRent, Inc. (SMRT)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SmartRent, Inc. (“SmartRent” or “the Company”) (NYSE: SMRT). Investors who purchased SmartRent securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether SmartRent has violated federal… read more
July 30, 2024 |
Bally’s Corporation (BALY)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bally’s Corporation (“BALY” or “the Company”) (NYSE: BALY). Investors who purchased BALY securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether BALY has violated federal… read more